Daily assessment of pain in adults with sickle cell disease
- PMID:18195334
- DOI: 10.7326/0003-4819-148-2-200801150-00004
Daily assessment of pain in adults with sickle cell disease
Abstract
Background: Researchers of sickle cell disease have traditionally used health care utilization as a proxy for pain and underlying vaso-occlusion. However, utilization may not completely reflect the amount of self-reported pain or acute, painful episodes (crises).
Objective: To examine the prevalence of self-reported pain and the relationship among pain, crises, and utilization in adults with sickle cell disease.
Design: Prospective cohort study.
Setting: Academic and community practices in Virginia.
Patients: 232 patients age 16 years or older with sickle cell disease.
Measurements: Patients completed a daily diary for up to 6 months, recording their maximum pain (on a scale of 0 to 9); whether they were in a crisis (crisis day); and whether they used hospital, emergency, or unscheduled ambulatory care for pain on the previous day (utilization day). Summary measures included both simple proportions and adjusted probabilities (for repeated measures within patients) of pain days, crisis days, and utilization days, as well as mean pain intensity.
Results: Pain (with or without crisis or utilization of care) was reported on 54.5% of 31 017 analyzed patient-days (adjusted probability, 56%). Crises without utilization were reported on 12.7% of days and utilization on only 3.5% (unadjusted). In total, 29.3% of patients reported pain in greater than 95% of diary days, whereas only 14.2% reported pain in 5% or fewer diary days (adjusted). The frequency of home opiate use varied and independently predicted pain, crises, and utilization. Mean pain intensity on crisis days, noncrisis pain days, and total pain days increased as the percentage of pain days increased (P < 0.001). Intensity was significantly higher on utilization days (P < 0.001). However, utilization was not an independent predictor of crisis, after controlling for pain intensity.
Limitations: The study was done in a single state. Patients did not always send in their diaries.
Conclusion: Pain in adults with sickle cell disease is the rule rather than the exception and is far more prevalent and severe than previous large-scale studies have portrayed. It is mostly managed at home; therefore, its prevalence is probably underestimated by health care providers, resulting in misclassification, distorted communication, and undertreatment.
Comment in
- Summaries for patients. Pain and health care visits in patients with sickle cell disease.[No authors listed][No authors listed]Ann Intern Med. 2008 Jan 15;148(2):I36. doi: 10.7326/0003-4819-148-2-200801150-00001.Ann Intern Med. 2008.PMID:18195331No abstract available.
Similar articles
- Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project.McClish DK, Levenson JL, Penberthy LT, Roseff SD, Bovbjerg VE, Roberts JD, Aisiku IP, Smith WR.McClish DK, et al.J Womens Health (Larchmt). 2006 Mar;15(2):146-54. doi: 10.1089/jwh.2006.15.146.J Womens Health (Larchmt). 2006.PMID:16536678
- Summaries for patients. Pain and health care visits in patients with sickle cell disease.[No authors listed][No authors listed]Ann Intern Med. 2008 Jan 15;148(2):I36. doi: 10.7326/0003-4819-148-2-200801150-00001.Ann Intern Med. 2008.PMID:18195331No abstract available.
- Comparisons of high versus low emergency department utilizers in sickle cell disease.Aisiku IP, Smith WR, McClish DK, Levenson JL, Penberthy LT, Roseff SD, Bovbjerg VE, Roberts JD.Aisiku IP, et al.Ann Emerg Med. 2009 May;53(5):587-93. doi: 10.1016/j.annemergmed.2008.07.050. Epub 2008 Oct 16.Ann Emerg Med. 2009.PMID:18926599
- Approach to the vaso-occlusive crisis in adults with sickle cell disease.Yale SH, Nagib N, Guthrie T.Yale SH, et al.Am Fam Physician. 2000 Mar 1;61(5):1349-56, 1363-4.Am Fam Physician. 2000.PMID:10735342Review.
- [Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy].Dickerhoff R, von Ruecker A.Dickerhoff R, et al.Klin Padiatr. 1995 Nov-Dec;207(6):321-5. doi: 10.1055/s-2008-1046561.Klin Padiatr. 1995.PMID:8569133Review.German.
Cited by
- Peer Mediated Groups:: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease.Guarino S, Wright CS, Pachter LM, Lanzkron SM.Guarino S, et al.Dela J Public Health. 2022 Oct 28;8(4):8-11. doi: 10.32481/djph.2022.10.004. eCollection 2022 Oct.Dela J Public Health. 2022.PMID:36340952Free PMC article.No abstract available.
- Depressive and Insomnia Symptoms Sequentially Mediate the Association Between Racism-Based Discrimination in Healthcare Settings and Clinical Pain Among Adults With Sickle Cell Disease.McGill LS, Hamilton KR, Letzen JE, Finan PH, Lanzkron SM, Smith MT, Haythornthwaite JA, Campbell CM.McGill LS, et al.J Pain. 2023 Apr;24(4):643-654. doi: 10.1016/j.jpain.2022.11.004. Epub 2022 Nov 20.J Pain. 2023.PMID:36414154Free PMC article.
- Marijuana use and health behaviors in a US clinic sample of patients with sickle cell disease.Wilson JD, Pecker LH, Lanzkron S, Bediako SM, Han D, Beach MC.Wilson JD, et al.PLoS One. 2020 Jul 14;15(7):e0235192. doi: 10.1371/journal.pone.0235192. eCollection 2020.PLoS One. 2020.PMID:32663844Free PMC article.
- Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease.He Y, Guo X, Wang ZJ.He Y, et al.Haematologica. 2023 Feb 1;108(2):633-637. doi: 10.3324/haematol.2022.281716.Haematologica. 2023.PMID:36300778Free PMC article.No abstract available.
- Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review.Lee S, Vania DK, Bhor M, Revicki D, Abogunrin S, Sarri G.Lee S, et al.Int J Gen Med. 2020 Jul 7;13:361-377. doi: 10.2147/IJGM.S257340. eCollection 2020.Int J Gen Med. 2020.PMID:32753936Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical